<DOC>
	<DOCNO>NCT00147446</DOCNO>
	<brief_summary>There grow body literature show stressful life event increase risk develop exacerbation new brain lesion among people multiple sclerosis . The purpose study examine hypothesis stress management program reduce occurrence new brain lesion exacerbation . We also examine potential immune neuroendocrine pathway .</brief_summary>
	<brief_title>Stress Management Patients With Multiple Sclerosis</brief_title>
	<detailed_description>MS frequently disable autoimmune disease affect approximately 350,000 people United States . More two decade research consistently show relationship stressful life event ( SLEs ) , particular non-traumatic family work stressor , subsequent clinical exacerbation . Furthermore , show non-traumatic SLEs increase risk subsequent appearance new gadolinium enhancing ( Gd+ ) magnetic resonance imaging ( MRI ) brain lesion , early marker MS inflammation blood-brain barrier ( BBB ) breakdown . The purpose study determine efficacy cognitive behavioral stress management MS ( CBSM-MS ) reduce occurrence new brain lesion people relapse form MS . Patients must document new Gd+ MRI brain lesion clinical exacerbation within previous 12 month enrol . One hundred twelve patient enrol 12 month . Patients randomly assign either intensive CBSM-MS program , consist 16 individual meeting behavioral medicine specialist , condensed CBSM-MS program , consist one-day workshop offer 10th month participation . Outcomes include MRI , clinical neurological end-points , psychosocial functioning . We also enhance understand mechanism examine potential psychosocial , immune , endocrine mediator relationship SLEs clinical neuroimaging marker MS inflammation .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Confirmed diagnosis MS New Gd+ MRI brain lesion clinically diagnose exacerbation within previous 12 month . Able speak english . Age 18 . Able give inform consent . Patients take drug glatiramer acetate must drug least 6 month prior Gd+ MRI brain lesion and/or exacerbation . Patients take interferon beta drug must drug least 1 month prior Gd+ MRI brain lesion and/or exacerbation . Patients disease modify treatment plan initiate treatment . Meets criteria dementia score 5th percentile 3 6 area neuropsychological functioning determine study neuropsychologist . Severe psychiatric pathology , include schizophrenia , bipolar disorder , current alcoholism substance abuse , severe psychiatric disorder intervention would inappropriate . Active severe suicidal ideation . Endocrine metabolic disorder . Currently psychotherapy . Initiated antidepressant therapy within past 4 week . Received corticosteroid treatment within past 28 day . Pregnant plan pregnancy next 12 month . Has nonremovable metal medical device body MRI could pose danger . Has risk factor develop nephrogenic systemic fibrosis ( NSF ) allergic Gadolinium . Currently use Baclofen pump . Has Expanded Disability Status Scale score great 6.5 . Recently begin relaxation , meditation , yoga , similar form disease management course within past 3 month . Treatment Chemotherapy . Treatment Tysabri .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Stress</keyword>
	<keyword>Stress Management</keyword>
	<keyword>Behavioral Medicine</keyword>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Psychoneuroimmunology</keyword>
</DOC>